Pricing Log in Create free account
Saturday 17 October 2026 Export HSIC’s income statement to Excel — free account

Henry Schein, Inc.

HSIC Healthcare Medical Distribution

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

86.38 0.61 −0.70%
Market cap
$9.7B
P/E
25.0×
Fwd P/E
18.5×
Dividend yield
—
F-score
5/9
Altman Z
2.66
Beneish M
−2.51
Dividend safety
69/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Henry Schein, Inc. (HSIC) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Henry Schein, Inc. (HSIC) trades at a P/S ratio of 0.7×. Over the past ten years it has ranged from 0.6× (October 2025) to 1.6× (December 2018); the current reading is higher than 18% of that period. That is above the Medical Distribution industry median of 0.3× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 0.7× 0.04%
FY2024 0.7× (13.45%)
FY2023 0.8× (6.60%)
FY2022 0.9× (2.22%)
FY2021 0.9× (6.99%)
FY2020 0.9× (4.66%)
FY2019 1.0× (1.06%)
FY2018 1.0× 0.91%
FY2017 1.0× 15.80%
FY2016 0.9× (11.66%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 0.7× 10.06%
Mar 2026 0.6× (8.62%)
Dec 2025 0.7× 12.33%
Sep 2025 0.6× (11.57%)
42 more quarters

Against its own ten years

Low 0.6× High 1.6×
Ten-year median 0.9×
Current reading's percentile 20

P/S ratio against peers

Company P/S ratio
ACH Accendra Health, Inc. compare 0.0×
COR Cencora, Inc. compare 0.2×
CAH Cardinal Health, Inc. compare 0.2×
COSM Cosmos Health Inc. compare 0.3×
MCK McKesson Corporation compare 0.3×
HSIC Henry Schein, Inc. 0.7×
AHG Akso Health Group Sponsored ADR compare 1.1×
FOCL FocalTherics compare 1.9×
HKPD Cellyan Biotechnology Co., Ltd compare —
Medical Distribution industry median 0.3×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on HSIC